Modifications of therapeutic proteins: challenges and prospects.
about
Human immunoglobulin allotypes: possible implications for immunogenicityImmunogenicity of Biotherapeutics: Causes and Association with Posttranslational ModificationsHib Vaccines: Past, Present, and Future PerspectivesLactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposesSite-specific functionalization of proteins and their applications to therapeutic antibodiesCell factories for insulin productionTechnological Microbiology: Development and ApplicationsA multi-omics analysis of recombinant protein production in Hek293 cells.Rational development of a strategy for modifying the aggregatibility of proteins.Conjugated critical reagent characterization for ligand-binding assays: using MALDI-TOF-MS as an orthogonal tool to assess assay performance.Rendering protein-based particles transiently insoluble for therapeutic applications.Chemical modifications in aggregates of recombinant human insulin induced by metal-catalyzed oxidation: covalent cross-linking via michael addition to tyrosine oxidation products.Modulation of self-association and subsequent fibril formation in an alanine-rich helical polypeptide.Macromolecular diffusion and release from self-assembled beta-hairpin peptide hydrogels.Microbial factories for recombinant pharmaceuticalsIdentification of Methionine Oxidation in Human Recombinant Erythropoietin by Mass Spectrometry: Comparative Isoform Distribution and Biological Activity Analysis.Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumabBiological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications.Quality control and stability studies with the monoclonal antibody, trastuzumab: application of 1D- vs. 2D-gel electrophoresis.Thermal stability engineering of Glomerella cingulata cutinase.Visual Detection of Denatured Glutathione Peptides: A Facile Method to Visibly Detect Heat Stressed Biomolecules.Investigation of purification process stresses on erythropoietin peptide mapping profile.Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.A kinetic-metabolic model based on cell energetic state: study of CHO cell behavior under Na-butyrate stimulation.Controlled Exposure of Bioactive Growth Factor in 3D Amyloid Hydrogel for Stem Cells Differentiation.Separation and analysis of charged isomers of monoclonal immunoglobulin G by ceramic hydroxyapatite chromatography.
P2860
Q24651893-C2EDE4EB-FA27-406B-BB9C-8887D3A246CDQ26738810-242761B0-DC93-423E-B5AF-06DD394CE6B6Q26767144-723C1070-E3DB-4672-A286-B0AAD9CCFF8DQ26786083-D9D15168-628B-4B0C-9488-FDA81A298646Q26830699-D0046D95-F364-4AEC-9109-BBEE36F5579EQ27000550-C6F9DB18-59DD-43E5-B635-CCB564B131C7Q30250972-3A8732AD-C85F-42F2-8B30-5A5D17C55B78Q34399137-551AA2D0-90BA-462D-BE17-C58840E87774Q34694133-ECCFA25D-FB65-41F2-9080-BDC2865A0D50Q35164795-A0B2EA99-1A8F-4604-9A88-5548AD609CB0Q36002525-1B7A97EB-0784-487E-9FB5-5D7D3A953EBAQ36101274-2263390F-E657-44DF-BB94-675A5544F08DQ37021694-78697E3A-641A-4735-AC36-388ADB3ECEE3Q37097067-BD143AA2-5BF1-475E-8997-23ED8977FED7Q37160231-1D5B75C1-4675-41CB-9E30-3D316D20FFC7Q38616210-DE37B5A7-9E0D-4164-96BD-DF1F279577F2Q38823875-E258183E-91E9-4053-B4AD-CEC28CE4020AQ39149359-2D62923D-4CF7-44B6-B75D-6688EDA33E26Q39357941-75D0C581-137C-4B2D-A9CF-7A0C2FE7534EQ39455749-420A55B6-291B-408A-A9B1-B6AB3493B863Q41880923-543BAD30-F52F-48C6-B2FC-3522764AF443Q42010530-C54B8A7D-CE8D-4097-A3D7-FCF04AD2541FQ42770604-AEE66290-5253-41FA-8060-8BBD0B9EAD48Q44828146-8822E271-DD97-4B27-9DF7-E6FBB2C38EF6Q47889447-9A5085A1-72E2-47E4-BF99-9A63BF7A7F58Q53643307-827808AB-F5AC-452C-B6D8-0837F6C1E4C3
P2860
Modifications of therapeutic proteins: challenges and prospects.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Modifications of therapeutic proteins: challenges and prospects.
@ast
Modifications of therapeutic proteins: challenges and prospects.
@en
type
label
Modifications of therapeutic proteins: challenges and prospects.
@ast
Modifications of therapeutic proteins: challenges and prospects.
@en
prefLabel
Modifications of therapeutic proteins: challenges and prospects.
@ast
Modifications of therapeutic proteins: challenges and prospects.
@en
P2860
P1433
P1476
Modifications of therapeutic proteins: challenges and prospects.
@en
P2093
Nigel Jenkins
P2860
P2888
P304
P356
10.1007/S10616-007-9075-2
P577
2007-04-01T00:00:00Z